Open the mobile version, with barcode scanning
Class III Terminated

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only.

Why: Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Company
Gilead Sciences, Inc.
Foster City, CA, United States
Reported
Mar 5, 2014
Recall started
Feb 19, 2014
Ended
May 11, 2015
Where sold
Nationwide including Puerto Rico.
Amount
39,223 bottles
Full product description
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland
Lots / codes affected
Lot #'s: 002390, 002400, Exp 02/17.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.